Firas H Kobaissy

Title: Firas H Kobaissy: Innovator in Traumatic Brain Injury Biomarkers

Introduction

Firas H Kobaissy is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of traumatic brain injury (TBI) research. His work focuses on identifying biomarkers that can aid in the diagnosis and recovery of TBI patients.

Latest Patents

Kobaissy holds a patent for "Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury." This patent highlights the role of collapsin response mediator proteins (CRMPs) in neural injury. His research indicates that CRMPs decrease in tissue and increase in biological fluids following TBI. Notably, significant decreases of CRMP1, CRMP2, CRMP4, and CRMP5 were observed, along with the emergence of distinct breakdown products from proteolytic cleavage by calpain. Additionally, synaptotagmin breakdown products were associated with TBI and could be detected in human cerebral spinal fluid (CSF). Both biomarkers are crucial for understanding recovery from traumatic brain injury.

Career Highlights

Throughout his career, Kobaissy has worked with various organizations, including Banyan Biomarkers, Inc. and the University of Florida Research Foundation Inc. His innovative research has positioned him as a key figure in the study of TBI biomarkers.

Collaborations

Kobaissy has collaborated with notable colleagues such as Andrew K Ottens and Ka-Wang (Kevin) Wang. These partnerships have furthered the research and development of effective biomarkers for TBI.

Conclusion

Firas H Kobaissy's contributions to the field of traumatic brain injury research are invaluable. His innovative work on biomarkers has the potential to significantly impact the diagnosis and treatment of TBI.